Eigil Kjeldsen

4.0k total citations
99 papers, 2.6k citations indexed

About

Eigil Kjeldsen is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eigil Kjeldsen has authored 99 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 48 papers in Molecular Biology and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eigil Kjeldsen's work include Acute Myeloid Leukemia Research (38 papers), Acute Lymphoblastic Leukemia research (24 papers) and Cancer therapeutics and mechanisms (17 papers). Eigil Kjeldsen is often cited by papers focused on Acute Myeloid Leukemia Research (38 papers), Acute Lymphoblastic Leukemia research (24 papers) and Cancer therapeutics and mechanisms (17 papers). Eigil Kjeldsen collaborates with scholars based in Denmark, Sweden and United States. Eigil Kjeldsen's co-authors include Ole Westergaard, Peter Hokland, Henrik Hasle, Boe Sandahl Sørensen, Jan Alsner, Jan Maxwell Nørgaard, Birgitta R. Knudsen, Lene Olesen, Fritz Boege and Jesper Q. Svejstrup and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Eigil Kjeldsen

96 papers receiving 2.6k citations

Peers

Countries citing papers authored by Eigil Kjeldsen

Since Specialization

Citations

This map shows the geographic impact of Eigil Kjeldsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eigil Kjeldsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eigil Kjeldsen more than expected).

Fields of papers citing papers by Eigil Kjeldsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eigil Kjeldsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eigil Kjeldsen. The network helps show where Eigil Kjeldsen may publish in the future.

Co-authorship network of co-authors of Eigil Kjeldsen

This figure shows the co-authorship network connecting the top 25 collaborators of Eigil Kjeldsen. A scholar is included among the top collaborators of Eigil Kjeldsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eigil Kjeldsen. Eigil Kjeldsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of the WHO and ICC Classifications of Cytogenetic Abnormalities in Childhood Acute Myeloid Leukemia 2024 ·Blood ·(unknown), (unknown), Morten Krogh Herlin, Jonas Abrahamsson, Nira Arad‐Cohen, Daniel KL Cheuk, Barbara De Moerloose, José María Fernández Navarro, Linda Fogelstrand, Kirsi Jahnukainen, Gertjan J.L. Kaspers, (unknown), Monica Cheng Munthe‐Kaas, Ulrika Norén‐Nyström, Josefine Palle, (unknown), Cornelis Jan Pronk, (unknown), Eigil Kjeldsen, Henrik Hasle	1
2	The real-world outcomes of multiple myeloma patients treated with daratumumab 2021 ·PLoS ONE ·(unknown), Tobias Wirenfeldt Klausen, (unknown), Birgitte Preiss, Carsten Helleberg, (unknown), Emil Hermansen, Lise Mette Rahbek Gjerdrum, (unknown), (unknown), Eigil Kjeldsen, (unknown), (unknown), (unknown), (unknown), (unknown), Mette Klarskov Andersen, Annette Juul Vangsted	14
3	Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients 2021 ·Hematological Oncology ·(unknown), Henrik Gregersen, (unknown), Tobias Wirenfeldt Klausen, (unknown), Birgitte Preiss, Carsten Helleberg, (unknown), Emil Hermansen, Lise Mette Rahbek Gjerdrum, (unknown), (unknown), Eigil Kjeldsen, (unknown), (unknown), (unknown), (unknown), Mette Klarskov Andersen, Annette Juul Vangsted	2
4	Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype 2021 ·Blood ·Henrik Hasle, Ronald M. Kline, Eigil Kjeldsen, (unknown), (unknown), Jeffrey M. Verboon, Stephanie DiTroia, Katherine R. Chao, Klas Raaschou‐Jensen, Josefine Palle, C. Michel Zwaan, Charlotte Guldborg Nyvold, Vijay G. Sankaran, Alan Cantor	16
5	Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma 2020 ·Experimental Hematology ·Marcus Høy Hansen, Oriane Cédile, (unknown), (unknown), Lene Hyldahl Ebbesen, (unknown), Mads Thomassen, Torben A. Kruse, (unknown), Eigil Kjeldsen, Thomas Kielsgaard Kristensen, Jacob Haaber, Niels Abildgaard, Charlotte Guldborg Nyvold	7
6	Addressing the room for improvement in management of acute promyelocytic leukemia 2019 ·European Journal Of Haematology ·Jan Maxwell Nørgaard, Lone S. Friis, (unknown), Marianne Tang Severinsen, Ingolf Mølle, Claus Werenberg Marcher, Peter Rask Møller, (unknown), Ove Juul Nielsen, Birgitte Preiss, Mette Klarskov Andersen, Eigil Kjeldsen, Bruno C. Medeiros, Lene Sofie Granfeldt Østgård, (unknown)	4
7	Oligo-based aCGH analysis reveals cryptic unbalanced der(6)t(X;6) in pediatric t(12;21)-positive acute lymphoblastic leukemia 2016 ·Experimental and Molecular Pathology ·Eigil Kjeldsen	4
8	Paternal Hemizygosity in 11p15 in Mole-like Conceptuses 2015 ·Medicine ·Lone Sunde, (unknown), Neil J. Sebire, Anni Grove, Rosemary A. Fisher, Isa Niemann, Eigil Kjeldsen, (unknown), Estrid Stæhr Hansen, Anders Bojesen, Lars Bolund, Mette Nyegaard	6
9	A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome 2015 ·Experimental and Molecular Pathology ·Eigil Kjeldsen	1
10	A novel acquired inv(2)(p23.3q24.3) with concurrent submicroscopic deletions at 2p23.3, 2p22.1, 2q24.3 and 1p13.2 in a patient with chronic thrombocytopenia and anemia 2015 ·Molecular Cytogenetics ·Eigil Kjeldsen	3
11	Exploring the genome-wide relation between copy number status and microRNA expression 2014 ·Genomics ·(unknown), Eigil Kjeldsen	9
12	DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype 2013 ·Cellular Oncology ·Eigil Kjeldsen, (unknown)	7
13	Kinetics of del(7q) driven leukemogenesis in a patient with JAK2 V617F and TET2 mutated chronic myeloproliferative neoplasm 2013 ·Leukemia Research Reports ·(unknown), Line Nederby, Eigil Kjeldsen, Kirsten Grønbæk, Peter Hokland, (unknown), Marcus Høy Hansen, Anne Stidsholt Roug	1
14	Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays 2012 ·Cellular Oncology ·Emilia Wiecheć, Jens Overgaard, Eigil Kjeldsen, Lise Lotte Hansen	6
15	Paediatric B‐cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols 2011 ·British Journal of Haematology ·Mette Klarskov Andersen, K. Autio, Gisela Barbany, Georg Borgström, Lucia Cavelier, Irina Golovleva, Sverre Heim, (unknown), Randi Hovland, Jóhann Heiðar Jóhannsson, Bertil Johansson, Eigil Kjeldsen, Ann Nordgren, Lars Palmqvist, Erik Forestier	24
16	Real-Time Quantitative PCR of Microdissected Paraffin-Embedded Breast Carcinoma 2004 ·Journal of Molecular Diagnostics ·Lise Mette Rahbek Gjerdrum, Boe Sandahl Sørensen, Eigil Kjeldsen, Flemming Brandt Sørensen, Ebba Nexø, Stephen Hamilton‐Dutoit	91
17	Prospective application of a multiplex reverse transcription‐polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single‐laboratory study of 390 paediatric and adult patients 2004 ·British Journal of Haematology ·Lene Olesen, Niels Clausen, (unknown), Gitte Kerndrup, Eigil Kjeldsen, Peter Hokland	27
18	Active, but not inactive, human centromeres display topoisomerase II activity in vivo 2002 ·Chromosome Research ·Claus L. Andersen, (unknown), Eigil Kjeldsen, Christian Mielke, Jørn Koch	24
19	FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara‐C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia 2001 ·European Journal Of Haematology ·Jan Maxwell Nørgaard, Lene Olesen, G. Olesen, (unknown), (unknown), Knud Bendix, Bent Pedersen, Eigil Kjeldsen, Peter Hokland	11
20	Acute leukemia cytogenetics 2001 ·Cancer Genetics and Cytogenetics ·Gitte Kerndrup, Eigil Kjeldsen	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact